Update virale Infektionen des ZNS

Virale Enzephalitiden sind hierzulande vergleichsweise selten geworden, gehören aber weltweit immer noch zu den häufigsten neurologischen Erkrankungen. Durch Fernreisen und sog. emerging Viruses könnten die Zahlen jedoch auch in Westeuropa wieder dramatisch zunehmen. Kenntnisse zu viralen Infektionen des ZNS sind insofern im klinischen Alltag unabdingbar, um rasche und richtige Therapieentscheidungen treffen zu können.

Schlüsselwörter

virale Enzephalitis - Neuro-Aids - emerging Viruses - Neurologie - neurokognitive Störung

• Literatur

• 1 Parpia AS, Li Y, Chen C. et al. Encephalitis, Ontario, Canada, 2002–2013. Emerg Infect Dis 2016; 22: 426-432
• 2 Maschke M. Virale Entzündungen des ZNS. In: Diener HC, Gerloff C, Dieterich M. Therapiehandbuch Neurologie. 7. Aufl. Stuttgart: Kohlhammer Verlag; 2017
• 3 GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18: 459-480
• 4 Karin H, Ylva B, Sandra S. et al. Monkeypox virus-associated meningoencephalitis diagnosed by detection of intrathecal antibody production. BMC Infect Dis 2024; 24: 94
• 5 Robert-Koch Institut. Epidemiologisches Bulletin Nr. 48/2024. Accessed October 13, 2024 at: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2024/Ausgaben/28_24.pdf?__blob=publicationFile
• 6 Mailles A, Stahl JP. Steering Committee and Investigators Group. Infectious encephalitis in France in 2007: a national prospective study. Clin Infect Dis 2009; 49: 1838-1847
• 7 Herlin LK, Hansen KS, Bodilsen J. et al. Varicella zoster virus encephalitis in Denmark from 2015 to 2019 – a nationwide prospective cohort study. Clin Infect Dis 2021; 72: 1192-1199
• 8 Robert-Koch Institut. MPox in Deutschland. Accessed October 13, 2024 at: https://www.rki.de/DE/Content/InfAZ/A/Affenpocken/Ausbruch-2022-Situation-Deutschland.html
• 9 Robert-Koch Institut. Epidemiologisches Bulletin Nr. 46/2023. Accessed October 13, 2024 at: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2023/Ausgaben/46_23.pdf?__blob=publicationFile
• 10 Robert-Koch Institut. Epidemiologisches Bulletin Nr. 29/2024. Accessed October 13, 2024 at: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2024/Ausgaben/29_24.pdf?__blob=publicationFile
• 11 Singh TD, Fugate JE, Hocker S. et al. Predictors of outcome in HSV encephalitis. J Neurol 2016; 263: 277-289
• 12 Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA 2013; 310: 308-15
• 13 Maschke M, Kastrup O, Diener HC. CNS manifestations of cytomegalovirus infections: diagnosis and treatment. CNS Drugs 2002; 16: 303-315
• 14 Pruitt AA. Infections of the cerebellum. Neurol Clin 2014; 32: 1117-31
• 15 Arendt G, Hahn K, Maschke M. et al. Neues bei HIV und Neuro-Aids. Akt Neurol 2015; 42: 445-455
• 16 Eggers C, Arendt G, Hahn K. et al. German Association of Neuro-AIDS und Neuro-Infectiology (DGNANI. HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.. J Neurol 2017; 264: 1715-1727
• 17 Antinori A, Arendt G, Becker JT. et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69: 1789-1799
• 18 The UK Collaborative HIV Cohort (CHIC) Study Steering Committee. HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era. Eur J Neurol 2011; 18: 527-534
• 19 Tan IL, Smith BR, von Geldern G. et al. HIV-associated opportunistic infections of the CNS. Lancet Neurol 2012; 11: 605-617
• 20 Armangue T, Spatola M, Vlagea A. et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol 2018; 17: 760-772
• 21 Armangué T, Olivé-Cirera G, Martínez-Hernandez E. et al. Neurologic complications in herpes simplex encephalitis: clinical, immunological and genetic studies. Brain 2023; 146: 4306-4319
• 22 Jarius S, Bieber N, Haas J. et al. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature. J Neurol 2022; 269: 5198-5212
• 23 Pohl D, Alper G, Van Haren K. et al. Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome. Neurology 2016; 87: S38-45
• 24 Otallah S. Acute disseminated encephalomyelitis in children and adults: a focused review emphasizing new developments. Mult Scler 2021; 27: 1153-1160
• 25 Kastrup O, Wanke I, Maschke M. Neuroimaging of infections of the central nervous system. Semin Neurol 2008; 28: 511-22
• 26 Ramli NM, Bae YJ. Structured imaging approach for viral encephalitis. Neuroimaging Clin N Am 2023; 33: 43-56
• 27 Marín-Medina DS, Castilla-Gómez L, Poveda M. et al. Encephalomyelitis in a patient with monkeypox: an unusual complication. J Neurovirol 2023; 29: 237-240
• 28 Westman G, Aurelius E, Ahlm C. et al. Cerebrospinal fluid biomarkers of brain injury, inflammation and synaptic autoimmunity predict long-term neurocognitive outcome in herpes simplex encephalitis. Clin Microbiol Infect 2021; 27: 1131-1136
• 29 Long F, Kong M, Wu SJ. Development and validation of an advanced fragment analysis-based assay for the detection of 22 pathogens in the cerebrospinal fluid of patients with meningitis and encephalitis. Clin Lab Anal 2019; 33: e22707
• 30 Bernhard-Nocht-Institut für Tropenmedizin: Diagnostischer Untersuchungsauftrag. Accessed October 13, 2024 at: https://www.bnitm.de/fileadmin/media/Labordiagnostik/Diagnostik/eschein_virologie_sep.-2024_01.pdf
• 31 Kasule S, Fernholz E, Grant L. et al. Whole-blood PCR preferred for timely diagnosis of neuroinvasive west nile virus infections: lessons from the 2021 Arizona outbreak. Open Forum Infect Dis 2024; 11: ofae188
• 32 Solomon T. DexEnceph: a study of dexamethasone in adults with herpes simplex virus (HSV) encephalitis. 2024 annual meeting American Academy of Neurology. Oral Presentation 16.04.2024.
• 33 Letendre S, Marquie-Beck J, Capparelli E. et al. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008; 65: 65-70
• 34 Heaton RK, Franklin DR Jr, Deutsch R. et al. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis 2015; 60: 473-80
• 35 Robert-Koch Institut. Konstituierende Sitzung der neuberufenen KRINKO. Accessed October 13, 2024 at: https://www.rki.de/DE/Content/Kommissionen/STIKO/Empfehlungen/
• 36 Velasco R, Mussetti A, Villagrán-García M. et al. CAR T-cell-associated neurotoxicity in central nervous system hematologic disease: is it still a concern?. Front Neurol 2023; 14: 1144414